Media and Investors Resources

Press Release, 21 April 2022

Adhoc Press Release

Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences’s MagnetOs Flex Matrix Cleared by FDA for Spinal Indications

Press Release, 16 March 2022

Adhoc Press Release

Kuros Biosciences reports results for the full year 2021

Kuros Annual Report, 2021

English version

Press Release, 3 February 2022

Kuros Biosciences’s MagnetOs Granules cleared by FDA for expanded spinal indications

Press Release, 20 January 2022

Kuros Biosciences publishes first-in-human clinical data for Fibrin-PTH (KUR-113) in treatment of open tibial shaft fractures

Press Release, 26 October 2021

Adhoc Press Release

Kuros Biosciences reports continued increase in MagnetOs U.S. sales